UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 208

Sortiert nach

A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants

BMC medicine, 2021-06, Vol.19 (1), p.138-138, Article 138

2021

Volltextzugriff (PDF)

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

Clinical and Vaccine Immunology, 2010-01, Vol.17 (1), p.154-159

2010

Volltextzugriff (PDF)

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

The Lancet (British edition), 2022-01, Vol.399 (10319), p.36-49

2022

Volltextzugriff (PDF)

Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age

Clinical and Vaccine Immunology, 2011-03, Vol.18 (3), p.367-372

2011

Volltextzugriff (PDF)

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

The Lancet (British edition), 2021-09, Vol.398 (10303), p.856-869

2021

Volltextzugriff (PDF)

Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator

Clinical infectious diseases, 2015-12, Vol.61 (11), p.1637-1644

2015

Volltextzugriff (PDF)

Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial

The Lancet infectious diseases, 2021-05, Vol.21 (5), p.688

2021

Volltextzugriff (PDF)

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial

The Lancet infectious diseases, 2021-05, Vol.21 (5), p.688-696

2021

Volltextzugriff (PDF)

Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy

Pediatrics (Evanston), 2016-07, Vol.138 (1)

2016

Volltextzugriff (PDF)

Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT

Pediatrics (Evanston), 2016-09, Vol.138 (3)

2016

Volltextzugriff (PDF)

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age

The Pediatric infectious disease journal, 2015-08, Vol.34 (8), p.865-874

2015

Volltextzugriff (PDF)

Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom

The Pediatric infectious disease journal, 2012-06, Vol.31 (6), p.616-622

2012

Volltextzugriff (PDF)

Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial

The Lancet. Microbe, 2023-05, Vol.4 (5), p.e300-e308

2023

Volltextzugriff (PDF)

Optimising the Timing of whooping cough Immunisation in MUMs: a randomised controlled trial investigating the timing of pertussis vaccination in pregnancy (OpTIMUM): a protocol paper

Wellcome open research, 2021, Vol.6, p.152

2021

Volltextzugriff (PDF)

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule

Vaccine, 2015-01, Vol.33 (5), p.648-655

2015

Volltextzugriff (PDF)

Variants in the genes encoding TNF-[alpha], IL-10, and GSTP1 influence the effect of [alpha]-tocopherol on inflammatory cell responses in healthy men

The American journal of clinical nutrition, 2012-06, Vol.95 (6), p.1461

2012

Volltextzugriff (PDF)

Variants in the genes encoding TNF-α, IL-10, and GSTP1 influence the effect of α-tocopherol on inflammatory cell responses in healthy men123

The American journal of clinical nutrition, 2012-06, Vol.95 (6), p.1461-1467

2012

Volltextzugriff (PDF)

Variants in the genes encoding TNF-α, IL-10, and GSTP1 influence the effect of α-tocopherol on inflammatory cell responses in healthy men

The American journal of clinical nutrition, 2012-06, Vol.95 (6), p.1461-1467

2012

Volltextzugriff (PDF)

Livestock herding and Fulani ethnicity are a combined risk factor for development of early adverse reactions to antivenom treatment: Findings from a cross-sectional study in Nigeria

PLoS neglected tropical diseases, 2021-08, Vol.15 (8), p.e0009518-e0009518

2021

Volltextzugriff (PDF)

Reticulin stain in differentiating astrocytomas from neurilemmomas on frozen sections. Technical note

Journal of neurosurgery, 1979-07, Vol.51 (1), p.124

1979

Volltextzugriff (PDF)

Cytotoxic Preproinsulin-specific CD8 T Cells in Type 1 Diabetes in Man

Clinical Immunology, 2007-01, Vol.123, p.S10-S10

2007

Volltextzugriff (PDF)

Clinical features and management of human monkeypox: a retrospective observational study in the UK

The Lancet infectious diseases, 2022-08, Vol.22 (8), p.1153-1162

2022

Volltextzugriff (PDF)

Biologically Inspired, Cell‐Selective Release of Aptamer‐Trapped Growth Factors by Traction Forces

Advanced materials (Weinheim), 2019-02, Vol.31 (7), p.e1806380-n/a

2019

Volltextzugriff (PDF)

An intermediate-effect size variant in UMOD confers risk for chronic kidney disease

Proceedings of the National Academy of Sciences - PNAS, 2022-08, Vol.119 (33), p.e2114734119-e2114734119

2022

Volltextzugriff (PDF)

Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

Lancet neurology, 2022-03, Vol.21 (3), p.234-245

2022

Volltextzugriff (PDF)

1 – 25 von 208

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(156)
Mit Volltextzugriff
(176)

Publikationsform

Artikel
(156)
Bücher
(24)
Texte
(18)
Buchkapitel
(4)
Berichte
(4)
Reviews
(1)
Webseiten
(1)

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants

Kinetics of Antibody Persistence following Administration of a Combination Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine in Healthy Infants in the United Kingdom Primed with a Monovalent Meningococcal Serogroup C Vaccine

Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial

Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age

Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial

Antibody Responses After Primary Immunization in Infants Born to Women Receiving a Pertussis-containing Vaccine During Pregnancy: Single Arm Observational Study With a Historical Comparator

Immunogenicity of the UK group B meningococcal vaccine : outcomes of a multicentre, open-label, randomised controlled trial

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial

Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy

Schedules for Pneumococcal Vaccination of Preterm Infants: An RCT

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age

Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom

Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial

Optimising the Timing of whooping cough Immunisation in MUMs: a randomised controlled trial investigating the timing of pertussis vaccination in pregnancy (OpTIMUM): a protocol paper

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule

Variants in the genes encoding TNF-[alpha], IL-10, and GSTP1 influence the effect of [alpha]-tocopherol on inflammatory cell responses in healthy men

Variants in the genes encoding TNF-α, IL-10, and GSTP1 influence the effect of α-tocopherol on inflammatory cell responses in healthy men123

Variants in the genes encoding TNF-α, IL-10, and GSTP1 influence the effect of α-tocopherol on inflammatory cell responses in healthy men

Livestock herding and Fulani ethnicity are a combined risk factor for development of early adverse reactions to antivenom treatment: Findings from a cross-sectional study in Nigeria

Reticulin stain in differentiating astrocytomas from neurilemmomas on frozen sections. Technical note

Cytotoxic Preproinsulin-specific CD8 T Cells in Type 1 Diabetes in Man

Clinical features and management of human monkeypox: a retrospective observational study in the UK

Biologically Inspired, Cell‐Selective Release of Aptamer‐Trapped Growth Factors by Traction Forces

An intermediate-effect size variant in UMOD confers risk for chronic kidney disease

Whole genome sequencing for the diagnosis of neurological repeat expansion disorders in the UK: a retrospective diagnostic accuracy and prospective clinical validation study

Suchergebnisse filtern